Email: cspc@cspc.cn

Contact Us

CSPC Pharmaceutical Group Co., Ltd.

News

News

Home > Media > News > VOLUNTARY ANNOUNCEMENT - CLINICAL DATA OF ALMB-0168 FOR THE TREATMENT OF OSTEOSARCOMA TO BE PRESENTED AT THE 2023 ASCO ANNUAL MEETING

VOLUNTARY ANNOUNCEMENT - CLINICAL DATA OF ALMB-0168 FOR THE TREATMENT OF OSTEOSARCOMA TO BE PRESENTED AT THE 2023 ASCO ANNUAL MEETING

June 05, 2023

Previous: CSPC Pharma Releases Latest Studies on SYSA1801 at ASCO Annual Meeting

Next: CSPC Amplifies Global Voice Stage Through Technological Innovation

Phone:

+86 311 8703 7015

Email:

Legal terms Privacy protection

Copyright © CSPC Pharmaceutical Group Co., Ltd. All Rights Reserved |